Matthew Blischak
Chief Executive Officer bij FINCH THERAPEUTICS GROUP, INC.
Profiel
Matthew P.
Blischak is currently the President, Chief Executive Officer & Secretary at Finch Therapeutics Group, Inc. Prior to his current position, he worked as the Vice President-Intellectual Property at Roivant Sciences, Inc. from 2018 to 2023.
Mr. Blischak completed his undergraduate degree at Case Western Reserve University and his graduate degrees at The Johns Hopkins University and American University Washington College of Law.
Actieve functies van Matthew Blischak
| Bedrijven | Functie | Begin |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Chief Executive Officer | 16-05-2023 |
Eerdere bekende functies van Matthew Blischak
| Bedrijven | Functie | Einde |
|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-04-2023 |
Opleiding van Matthew Blischak
| Case Western Reserve University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| American University Washington College of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Bedrijven in privébezit | 1 |
|---|---|
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
